You just read:

ImmunoCellular Therapeutics Reports Updated Immune Monitoring Data from ICT-107 Phase 2 Trial in Newly Diagnosed Glioblastoma at the Society for Neuro-Oncology Annual Meeting 2016

News provided by

ImmunoCellular Therapeutics, Ltd.

Nov 21, 2016, 06:00 ET